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Abstract
Hepatic capsular retraction refers to the loss of the normal
convex hepatic contour, with the formation of an area of flat-
tening or concavity. This can result from myriad causes, in-
cluding intrinsic hepatic conditions such as cirrhosis, biliary
obstruction, benign tumours, malignancy and infections, as
well as extrahepatic causes such as trauma. This article aims
to provide familiarity with this wide spectrum of conditions,
including mimics of hepatic capsular retraction, by highlight-
ing the anatomic, pathologic and imaging features that help
distinguish these entities from one another.
Teaching Points
• Hepatic capsular retraction can occur due to various intrin-
sic or extrinsic hepatic causes.
• Hepatic capsular retraction is observed in both benign and
malignant conditions.
• Recognising associated imaging features can help elicit
causes of hepatic capsular retraction.
Keywords Liver . Capsular retraction . Computed
tomography . Liver abnormalities . Pseudo-retraction
Introduction
Hepatic capsular distortion can occur in a variety of entities,
both intrahepatic and extrahepatic, including cirrhosis, benign
neoplasia, malignant distortion and hepatic trauma. This
article aims to provide familiarity with this wide spectrum of
conditions, as well as conditions that produce an appearance
mimicking hepatic capsular retraction on imaging, by
highlighting the anatomic, pathologic and imaging features
that help distinguish these entities from one another Table 1.
Hepatic capsule anatomy
The hepatic capsule is divided into two adherent layers, an outer
serous layer and an inner fibrous layer. The outer serous layer is
derived from the peritoneum and coversmost of the liver surface,
but not the bare area of the liver, which is near the diaphragm, the
porta hepatis, or the area where the gallbladder is attached to the
liver. The inner layer is a thick fibrous layer which consists of
type III collagen and extends to the stroma of endothelial sinu-
soids. Also known as Glisson’s capsule, this fibrous layer covers
the entire surface of the liver, unlike the outer serous layer [1].
Superficial to the liver parenchyma and deep to Glisson’s capsule
is a potential space, the subcapsular space, which has the poten-
tial to hold fluid, blood or cells (Fig. 1).
Neither the serous nor fibrous liver capsule is visible in normal
conditions under CT or MR imaging and maintains a strict ad-
herence to the liver parenchyma. It does become visible, howev-
er, in a number of entities both benign and malignant [2].
Hepatic capsular retraction is defined as loss of the normal
convex hepatic contour, an area of focal flattening or concavity.
This can be seen secondary to intrinsic subcapsular liver lesions,
which cause true capsular retraction by pulling the liver edge
away from the hepatic capsule. Alternatively, the loss of normal
convex hepatic contour can also be seen in a number of normal
variations such as accessory hepatic fissure and invagination of
the liver by the diaphragm. Pseudoretraction can also be demon-
stratedwhen fluid, blood and both benign andmalignant deposits
are seen in the subcapsular space. These typically have a
lentiform appearance and can give the liver edge a similar con-
cave appearance.
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Cirrhosis occurs in the setting of diffuse hepatocyte injury,
resulting in disruption of hepatic architecture with the forma-
tion of fibrous septae and regenerative nodules, both
micronodular (<3 mm) and macronodular (>3 mm) [3].
Imaging findings in cirrhosis include caudate lobe hypertro-
phy, atrophy of other lobes and parenchymal nodularity,
which is most apparent along the liver surface. This results
in distortion of the liver contour, most apparent in cases of
macronodular cirrhosis (Fig. 2). Micronodular cirrhosis may
not be apparent on imaging examinations.
Focal confluent fibrosis is one of the grossly demonstrable
patterns of fibrosis in advanced cirrhosis, most commonly
seen in alcoholic cirrhosis, where it can be mistaken for ma-
lignant neoplasia. It appears as a wedge-shaped area of low
attenuation on CT with volume loss. Ninety percent of cases
involve the medial segment of the left lobe and/or the anterior
segment of the right lobe, with sparing of the caudate and
lateral segments. Capsular retraction is also demonstrated in
90 % of cases, and has been found to increase with the evo-
lution of focal confluent fibrosis [4, 5] (Fig. 3). Eighty percent
of the time it is isodense to liver parenchyma on the portal
venous phase and shows delayed-phase hyper-enhancement
like other fibrotic liver lesions. On MRI, it is typically
hypointense to liver parenchyma on T1-weighted images
and hyperintense to the liver on T2-weighted images, due to
oedema and compressed remnants of the portal triads.
Typically, the lesions are hypointense to the liver on the im-
mediate post-contrast T1 sequences, with the more fibrotic
areas becoming isointense to the liver on the later dynamic
phases. These areas are typically hypo-enhancing in the


















Pseudolipoma of Glisson’s capsule*
*Mimics hepatic capsular retraction
Fig. 1 Schematic representation of the anatomy of the hepatic capsule.
Note that the subcapsular space is a potential space
Fig. 2 Portal venous CT demonstrates an irregular nodular liver, with the
capsule outlined by ascites. Note splenomegaly due to portal hypertension
Fig. 3 Dumbbell-shaped liver due to confluent fibrosis. This retracts the
capsule overlying segment 4 with a subtle heterogeneous area of hypo-
enhancement in segment 4. The remainder of the liver has a slightly
nodular contour due to cirrhosis
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hepatobiliary phase due to the paucity of hepatocytes. The
location, shape and enhancement characteristics help differen-
tiate confluent hepatic fibrosis from other differential diagno-
ses, which include cholangiocarcinoma, hepatocellular carci-
noma, biphenotypic hepatocholangiocarcinoma, hepatic in-
farction and epithelioid haemangioendothelioma.
Conventional hepatocellular carcinoma (HCC)
Hepatocellular carcinoma (HCC) is one of the leading causes of
cancer-related deaths worldwide, being the fifth most common
cancer in men and eighth most common cancer in women over-
all. Conventional HCC rarely contains fibrous tissue, and as
such, hepatic capsular retraction is very uncommon in conven-
tional HCC, although it can occur in the rarer subtypes that
contain a greater volume of fibrosis such as sclerotic and mixed
cholangio-HCC [6]. Capsular retraction in the setting of HCC is
most frequently encountered after treatment, either local or sys-
temic [7]. Transcatheter arterial chemo/radio-embolisation of he-
patocellular carcinoma is a widely used method in the treatment
of HCC. Chemoembolisation disrupts the arterial supply to
HCC, thus depriving it of its source of nutrients, leading to is-
chemic necrosis within the tumour [8]. This leads to atrophy of
the surrounding liver parenchyma and can cause capsular retrac-
tion of the liver (Fig. 4).
Cholangiocarcinoma
Cholangiocarcinoma is a malignant tumour arising from the bil-
iary tree, associated with poor prognosis and high morbidity [9].
It is the secondmost common primary malignant hepatic tumour
after hepatocellular carcinoma. Intrahepatic cholangiocarcinomas
can be classified into three types on the basis of their gross
morphologic features, with each type having its own character-
istic imaging findings. These three morphological classifications
are mass-forming, periductal-infiltrating and intraductal-growth
types [10]. The mass-forming type of cholangiocarcinoma is the
commonest and has themost recognised association with hepatic
capsular retraction [11]. Mass-forming cholangiocarcinoma pre-
sents as an irregular, markedly low-attenuation mass with mini-
mal irregular peripheral enhancement and focal dilatation of
intrahepatic ducts around the tumour. The central part of the
tumour does not enhance on arterial and portal venous phases,
and there may be prolonged enhancement on the delayed phase.
Capsular retraction occurs commonly in these tumours due to
their variable but typically marked central fibrosis (Fig. 5).
Features such as vascular encasement without grossly visible
tumour thrombus, as well as the presence of satellite nodules,
can help distinguish cholangiocarcinoma from other malignan-
cies. Clinically, cholangiocarcinoma typically occurs in patients
with pre-existing bile duct diseases such as biliary lithiasis,
clonorchiasis, recurrent pyogenic cholangitis or primary scleros-
ing cholangitis, although patients with chronic liver disease are
also at increased risk.
Hepatic metastases
Hepatic capsular retraction has a well-established association
with hepatic metastases, and in the past has erroneously been
claimed to be a specific sign for hepatic malignancy [12].
Metastases may cause capsular retraction in their own right, par-
ticularly with relatively fibrous primary tumours such as lung,
breast and colon carcinomas and carcinoids [12, 13] (Fig. 6).
Fig. 4 Coronal portal venous phase CT demonstrates washout in the
heterogeneous HCC filling much of the right lobe of liver. Capsular
retraction is present laterally with ascites filling the void
Fig. 5 Portal venous CT demonstrates capsular retraction (long arrow)
secondary to an infiltrating, hypo-enhancing cholangiocarcinoma (short
arrows). Note a satellite lesion in segment 2 (arrowhead)
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Breast cancer metastases in particular have been shown to be a
cause of massive capsular retraction, with both increases or de-
creases in the size of metastases, independent of tumour factors
and chemotherapy regime [14]. These areas of multifocal capsu-
lar retraction in breast cancer metastases have thus also been
classified as pseudocirrhosis of the liver [15–17]. Capsular retrac-
tion, however, is more commonly seen in metastases after they
have undergone treatment with chemotherapy, radiotherapy or
percutaneous ablation, as the subsequent necrosis can result in
fibrous scarring (Figs. 7 and 8). On imaging, hepatic metastases
vary widely in appearance, but are often multiple, spherical, and
tend to appear hypo-attenuating in comparison to the remaining
liver parenchyma on CT. Hypervascular metastases can be seen
in endocrine tumours such as islet cell, thyroid and carcinoid.
Narrowing metastases as the aetiology of capsular retraction is
often based on both imaging appearance and clinical information,
including a history of a primary malignancy and identification of
metastatic disease elsewhere.
Haemangioma
Hepatic haemangiomas are the most common benign tumour
of the liver, and are found in 5–20 % of the population, being
the most common liver tumour overall [18, 19]. They can
range in size from a few millimetres to greater than 20 cm,
and are arbitrarily termed ’giant’ haemangioma when they are
larger than 4 cm [20, 21]. Capsular retraction is not a typical
feature, and is believed to occur in haemangiomas which un-
dergo fibrous degeneration, although this is not always the
case [22]. In the setting of cirrhosis, Brancatelli et al. showed
capsular retraction in 24 % of haemangiomas [23]. In imaging
with both CT and MRI, haemangiomas show typical early
peripheral, nodular or globular discontinuous enhancement,
with progressive centripetal enhancement to uniform filling
on the venous phase. Sclerosed haemangiomas lack peripheral
nodular enhancement, do not progressively fill, and may have
reduced T2 signal within them. They are hypointense on the
hepatobiliary phase, and will frequently have reduced appar-
ent diffusion coefficient (ADC) values which mimic metasta-
tic disease. Due to this atypical appearance, histological sam-
pling is frequently required for definitive diagnosis (Figs. 9
and 10). Haemangiomas in cirrhotic livers may not demon-
strate the typical radiological features, and have been shown to
undergo progressive fibrosis and decrease in size, which likely
accounts for variation in imaging appearance.
Hepatic inflammatory pseudotumour
Inflammatory pseudotumour is an uncommon benign lesion
within the liver, which is histologically characterised by pro-
liferation of plasma cell histiocytes and other inflammatory
cells intermingled with varying degrees of fibrosis [24].
Hepatic inflammatory pseudotumour tends to occur in young
adult men, although it has been observed across all age groups
[24]. These pseudotumours often pose a diagnostic dilemma,
as they are difficult to differentiate frommalignant tumours on
Fig. 6 Portal venous phase CT demonstrates an enlarged liver with a
markedly irregular contour due to metastatic melanoma. The patient has
ascites and peritoneal deposits (arrow), and clinically was heavily
jaundiced, with gross hepatic dysfunction. Note normal-sized spleen
Pre-treatment Post-treatment
Fig. 7 & 8 Post-treatment CT
shows a small liver with nodular
contour on a background of
ascites but with a normal-sized
spleen. The patient had completed
chemotherapy for metastatic
breast carcinoma with multiple
hepatic metastases. The sites of
retraction correspond to sites of
tumour on the pre-treatment CT
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imaging [25]. Several case reports have demonstrated capsular
retraction associated with more peripheral hepatic inflamma-
tory pseudotumours (Fig. 9), thus initially raising concern for
an underlying malignant lesion such as cholangiocarcinoma,
which was later disproved by liver biopsy [25]. Given the non-
specific appearance of hepatic inflammatory pseudotumours,
liver biopsy remains the gold standard for diagnosis (Fig. 11).
Biliary obstruction
Both benign andmalignant causes of biliary obstruction can lead
to lobar atrophy within the liver, with the most common causes
being post-cholecystectomy stricture and cholangiocarcinoma
[26]. Benign strictures causing lobar or segmental biliary obstruc-
tion result in atrophy in the lobe or segment of the liver drained
by the obstructed duct [26]. Cholangiocarcinoma can also result
in atrophy secondary to biliary obstruction and/or portal vein
branch compromise [26]. In both scenarios, there is often
hypertrophy of the contralateral hepatic lobe. At the junction
between the atrophied and hypertrophied lobe or segment, there
is usually a change in hepatic contour, or ‘step’, which results in
distortion of the overlying hepatic capsule that canmimic hepatic
capsular retraction (Fig. 10). The pattern of atrophy is also influ-
enced by the biliary ductal anatomy, which has multiple normal
variants.
Infections
Hepatic abscesses, particularly those located peripherally, can
cause hepatic capsular retraction as they regress, even without
percutaneous drainage [27]. This relates to the associated scar-
ring and fibrosis during the recovery phase [27]. Similarly,
peripherally located hepatic hydatid cysts which have rup-
tured can also cause capsular retraction.
Clonorchiasis is a trematodiasis caused by chronic infestation
of Clonorchis sinensis, which can lead to recurrent pyogenic
cholangitis, biliary strictures and cholangiocarcinoma. It is ac-
quired after ingestion of raw flesh and freshwater fish in endemic
areas. At imaging, clonorchiasis is best diagnosed by cholangi-
ography, either directly (percutaneous transhepatic cholangiogra-
phy or endoscopic retrograde cholangiopancreatography
[ERCP] ) o r ind i r ec t ly v ia magne t i c re sonance
cholangiopancreatography (MRCP) or CT intravenous cholangi-
ography. In particular, radiologists should suspect clonorchiasis
when there is evidence of biliary obstruction with dilatation of
the peripheral intrahepatic ducts, without dilatation of the extra-
hepatic bile duct [28]. This biliary obstruction then results in
atrophy of that hepatic lobe and associated distortion of the over-
lying hepatic capsule. The best diagnostic clues for clonorchiasis
include hepatic atrophy and the presence of hyperdense
intrahepatic calculi, with a predilection for the left lobe of the
liver. Rarely, clonorchis sinensis can present as filling defects,
Fig. 9 & 10 Axial CT (upper image) demonstrates a non-enhancing low-
density solitary liver lesion with capsular retraction in a patient with newly
diagnosed rectal carcinoma. The density of the lesion is slightly greater than
the gallbladder. On T2-weighted MRI (lower image), the lesion is heteroge-
neous and hyperintense with capsular retraction. No enhancement was pres-
ent (not shown). The lesion was resected as a suspected mucinous metastatic
deposit, but histology showed a sclerosed haemangioma
Fig. 11 T2-weighted MRI demonstrates inflammatory pseudotumour as
a target type lesion with markedly hyperintense centre and a mildly
hyperintense margin in hepatic segment 5, with associated flattening of
the overlying hepatic capsule
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which can be a fewmillimetres to 10 mm long, with intrahepatic
duct dilatation (Fig. 12).
Fulminant hepatic necrosis
Fulminant hepatic failure is clinically characterised by acute
severe impairment of hepatic function, causing hepatic en-
cephalopathy within 8 weeks of jaundice [29]. In developing
countries, viral hepatitis is the leading cause of acute liver
failure, whereas in developed countries, drug-induced liver
injury, such as paracetamol overdose, is the primary cause
[29]. In fulminant hepatic failure, there is massive hepatocyte
necrosis, which appears as areas of hypodensity on CT imag-
ing [30]. If the patient survives, these large areas of necrosis
involute due to scarring and fibrosis, resulting in hepatic vol-
ume loss and retraction of the overlying hepatic capsule [31]
(Figs. 13 and 14). The formation of regenerating nodules also
contributes to the irregularity of the liver margin. These areas
of regenerating nodules are hyper-enhancing on contrast-
enhanced imaging compared with the devascularised non-
enhancing necrotic liver [31].
Extrahepatic causes
Diaphragm
Diaphragmatic slips can produce extrinsic indentations of
the liver which may mimic hepatic capsular retraction.
The key to diagnosis is to note that these are typically
obliquely oriented across the anatomical right lobe of
the liver, are multiple in number, and with each band of
indentation leading to a rib. The ribs are located at the
inferior aspect of the indentation (Fig. 15).
Trauma
Capsular retraction can be seen following liver trauma, both
penetrating and non-penetrating insults. The liver is the most
frequently injured organ in abdominal blunt trauma [32]. CT
features of both blunt and penetrating hepatic trauma include
hepatic lacerations, subcapsular and parenchymal
haematomas, active haemorrhage and juxtahepatic venous in-
juries. Capsular distortion can be seen in the acute phase of
trauma, with subcapsular haematomas presenting at CT as an
elliptic collection of blood trapped between the liver paren-
chyma and hepatic capsule. Parenchymal haematomas are
seen at CT as focal low-attenuation areas with poorly defined
irregular margins within the liver parenchyma on contrast-
enhanced CT (Figs. 16 and 17). Hepatic lacerations may also
cause bile leakage with biloma formation, which may result in
Fig. 12 Atrophy in the left lateral segment with distended bile ducts
secondary to clonorchiasis infection. Note the presence of a central
hyperdense intrahepatic ductal stone (arrow)
Fig. 13 & 14 Portal venous phase CT shows multiple hypo-enhancing
pseudomasses representing areas of hepatic necrosis with background of
ascites. This is biopsy-proven fulminant hepatic necrosis. The necrosis-
induced fibrosis and atrophy cause hepatic capsular retraction, and there
has been substantial volume loss comparedwith a CTperformed 7months
earlier (bottom image)
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necrosis of the surrounding hepatic parenchyma (Fig. 18). At
follow-up, a rare complication of trauma includes abscess for-
mation, both hepatic and perihepatic, and has been reported in
up to 4 % of blunt liver trauma not undergoing surgical man-
agement [33, 34]. Fibrosis as a result of healing of the hepatic
and perihepatic abscess can lead to capsular distortion (Fig.
19).
Iatrogenic hepatic trauma can also result in hepatic capsular
retraction due to the fibrosis and scarring during the healing
process [35]. This form of capsular retraction tends to be
localised, small and peripheral to the zone of injury, some-
times with adjacent hypodense areas of fibrosis [35].
Examples of procedures causing iatrogenic hepatic trauma
include liver biopsy, percutaneous biliary drainage or percu-
taneous drainage of hepatic abscesses or cysts, as well as par-
tial hepatectomy [35]. In these cases, a history of hepatic in-
terventions should alert the radiologist to the possibility of
iatrogenic hepatic trauma as a cause for hepatic capsular
retraction.
Treated tumours
Minimally invasive ablation techniques have increasingly im-
portant roles in the management of hepatic tumours, particu-
larly in patients who are unfit for surgery. Multiple ablation
techniques have been employed in the treatment of liver tu-
mours, including radiofrequency ablation (RFA),
cryoablation, high-intensity focused ultrasound (HIFU), etha-
nol injections and microwave ablation (MWA). These ablative
techniques result in coagulative necrosis of the tumour tissue,
which eventually involutes and is replaced by fibrous scar
tissue, which in turn can result in hepatic capsular retraction
[36, 37] (Figs. 20 and 21).
Pseudomyxoma peritonei
Pseudomyxoma peritonei is the diffuse accumulation of gelat-
inous ascites due to the rupture of well-differentiated mucin-
ous tumours. The most common cause is ruptured mucinous
tumour of the appendix [38]. Mucinous tumours of the colon,
rectum and pancreas and urachal tumours have also been
shown to cause pseudomyxoma peritonei [39]. There is some
controversy regarding pseudomyxoma peritonei due to
Fig. 15 Two hypo-enhancing extrinsic indentation over the lateral liver.
These appear linear on sequential slices (not shown) and each can be
followed to join an overlying rib
Fig. 16 & 17 Non-contrast CT
(left) showing a heterogenous
subcapsular haematoma indenting
the liver post liver biopsy. There
is no enhancement or active
bleeding on portal venous phase
(right). Note the heterogeneity of
the lesion with serum being anti-
dependent, and more solid
components of the haematoma
being dependently positioned
Fig. 18 Well-defined fluid attenuation subcapsular biloma indents the
liver following percutaneous transhepatic biliary intervention
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rupture of tumours of the ovary, and whether these are in fact
appendiceal tumour metastases rather than primary ovarian
tumours [40, 41]. On CT, pseudomyxoma peritonei appears
as low-attenuation, often loculated fluid throughout the peri-
toneum, omentum and mesentery. Scalloping of visceral sur-
faces, particularly in the liver, with distortion of the capsule is
a very typical feature and allows differentiation from simple
ascites. This capsular distortion may mimic hepatic capsular
retraction on imaging (Fig. 22). Curvilinear calcification may
also be present. OnMRI, the gelatinous ascites typically dem-
onstrates low signal on T1 and high signal on T2, and may
show some enhancement post-administration of gadolinium
contrast.
Pseudolipoma of Glisson’s capsule
A rare benign tumour of the liver, pseudolipoma of
Glisson’s capsule is an encapsulated lesion containing
necrotic fatty tissue, attached to the surface of the hepat-
ic capsule [42]. It is hypothesised to originate from a
torted, detached epiploic appendage, which becomes ad-
herent to the hepatic capsule [42]. On CT imaging, this
tumour appears as a well-defined nodule of fat attenua-
tion along the hepatic capsule, causing indentation of the
underlying hepatic parenchyma [43], which appears sim-
ilar to hepatic capsular retraction (Fig. 23). On MRI, it
demonstrates fat signal intensity [43]. On opposed-phase
T1-weighted images, the key feature is the presence of
an ‘india ink artefact’ between the pseudolipoma and the
Fig. 19 Surgical wedge resection with multiple surgical clips along the
cut liver surface, with the defect being filled with fat
Fig. 20 Axial portal venous CT demonstrating capsular retraction in
segment 7/8 with a hypo-enhancing ablation zone deep to it
Fig. 21 Hypo-enhancing focus with capsular retraction in segment 2, at a
site of radiofrequency ablation performed for hepatocellular carcinoma
12 months earlier
Fig. 22 Pseudomyxoma in a 60-year-old woman with ovarian carcinoma.
The peritoneal cavity is massively expanded and, under pressure, manifest as
compression and displacement of the liver. Note that the stretched
paraumbilical ligament still anchors the liver to the anterior abdominal wall
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liver, but not between the liver and adjacent fat (Fig. 24).
It is useful to consider pseudolipoma in the differential
diagnosis of hypodense hepatic capsular lesions, as it can
prevent unnecessary invasive investigations.
Conclusion
Hepatic capsular retraction is increasingly encountered and
may be due to a diverse spectrum of pathologies. A thorough
investigation of the region and correlation with patient history
can allow a specific diagnosis to be made.
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